Tech News

Q&A: i4i chairman adds up a $290M verdict vs. Microsoft

Earlier as we speak the U.S. Supreme Court docket ruled in favor of Toronto-based technology company i4i in a patent infringement lawsuit in opposition to Microsoft — rejecting the Redmond firm’s bid to decrease the usual for proving patents invalid at trial. The landmark resolution upholds a $290 million verdict in opposition to Microsoft.

GeekWire spoke by way of telephone with Loudon Owen, i4i’s chairman, concerning the ruling, its implications, and what the corporate plans to do subsequent.

How are you feeling? We’re gratified. It’s a tremendously necessary resolution for the trade, and it mushroomed from a case the place we have been imposing our property rights into one of the crucial necessary selections in enterprise legislation by the U.S. Supreme Court docket in many years.

The place now from right here for i4i? First and formost we get away from bed each morning as a result of we’re enthusiastic about what we do. The imaginative and prescient and the drive of Michael Vulpe who’s the founder and the co-inventor. That’s what we’re going to, we’re going to construct our enterprise and alter the way in which the world manages info for the higher. On the identical time, as individuals needs to be conscious by now, we’re going to proceed to develop mental property and we shall be vigilant to make certain that individuals don’t infringe upon our rights, and in the event that they do we are going to implement.

What merchandise are you going to offer? We have now a suite of merchandise and options at the moment addressing the vertical market in prescribed drugs, and the life-cycle of information administration. It’s customized XML, which capitalizes on XML to make sure you could construction unstructured knowledge. You may take simply mounds of information that in any other case simply a jumble of phrases, and you may successfully create a database out of it and handle it way more successfully, so the info synchronize. At the moment we’ve been specializing in the pharmaceutical vertical. We have now prior to now labored in a entire vary of vertical markets. We’ll proceed now to construct our enterprise and develop it into different verticals.

What are you going to do with the cash? We’re going to construct our enterprise. It’s humorous, we don’t actually deal with the cash, we’re probably not fascinated about it. It’s a step in a lengthy journey, and it’s an necessary subsequent step, however we’ll determine what to do with our board and our shareholders, and we’ll go ahead and construct our enterprise.

Back to top button